In our last episode, we discussed hyperkalemia management in an otherwise renally healthy patient. But what if your patient has chronic kidney disease? Are they okay if their potassium has been 5.9 for a long time? How does our management change? Nephrologist Dr. Jordan Symons returns to offer his advice on outpatient and inpatient management of acute-on-chronic hyperkalemia.
In this brief add-on episode, we’ll discuss the management of hyperkalemia in a patient with chronic kidney disease.
As a refresher (find more in the show notes for hyperkalemia part 1), potassium is essential for maintaining a resting cell potential, especially in the heart. Normal levels range from 3.5-5.5 meQ/mL. The most dangerous consequence of hyperkalemia is cardiac arrhythmias and arrest.
In a patient with chronic kidney disease, long term elevations of potassium are almost always related to problems with excretion, due to: low GFR, tubular dysfunction, distal secretion issues, or iatrogenic (potassium sparing diuretics, ACE inhibitors, calcineurin inhibitors, all of which are more likely to be prescribed medications in CKD).
Expert pearl: Every doubling of the serum creatinine means the GFR is cut in half, which can negatively affect secretion of many substances and electrolytes.
Expert opinion: many of the CKD patients are in the high 5s already for their potassium. It is important, then, to look at a patient’s potassium trends over time, and there is even a possibility of sending home for outpatient follow-up.
Expert practice: Potassium <6 is generally acceptable; potassium >6 warrants a closer look at context, such as recent changes in medication or diet.
Chronic hyperkalemia over time (approx 3-6 months according to our expert) is a bit safer because the cell membranes acclimate to higher levels of potassium. An exception is a patient who is also hypocalcemic, which will perturb the calcium:potassium ratio putting the patient at higher risk of cardiac arrhythmias.
The outpatient management of hyperkalemia consists of:
The management of hyperkalemia, if deemed acute, is much like the management for acute hyperkalemia in the non-CKD patient, with a few exceptions:
Listeners will explain the differences in chronic management of hyperkalemia in a patient with chronic kidney disease, both in the outpatient and inpatient setting.
Dr Symons reports no relevant financial disclosures. The Cribsiders report no relevant financial disclosures.
Zhang AY, Symons J, Masur S, Chiu C, Berk J. “#118: Even MORE Bananas, B-A-N-A-N-A-S: Hyperkalemia in CKD”. The Cribsiders Pediatric Podcast. https:/www.thecribsiders.com/ August 21, 2024.
Producer, writer, infographic: Angela Y Zhang, MD
Showrunner: Sam Masur, MD
Cover Art: Chris Chiu MD
Hosts: Angela Y Zhang, MD, Sam Masur MD, Chris Chiu MD
Editor: Clair Morgan of nodderly.com
Guest: Jordan Symons, MD
The Cribsiders have partnered with Penn Medicine Continuing Education to offer continuing education credit—including AMA PRA Category 1 Credit™ and ABP MOC Part 2—for physicians and other healthcare professionals. An annual subscription gives you unlimited access to the full course catalog. Enrol Now.
Got feedback? Suggest a Cribsiders topic. Recommend a guest. Tell us what you think.
We love hearing from you.

Yes, you can now join our exclusive community of core faculty at Kashlak Memorial Hospital along with all the perks:
Notice
We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes as specified in the cookie policy. Denying consent may make related features unavailable.
Close this notice to consent.